| Literature DB >> 29587719 |
Elizabeth M Wood1, Babalwa Zani2, Tonya M Esterhuizen3, Taryn Young2,3.
Abstract
BACKGROUND: Home-based care is used in many countries to increase quality of life and limit hospital stay, particularly where public health services are overburdened. Home-based care objectives for HIV/AIDS can include medical care, delivery of antiretroviral treatment and psychosocial support. This review assesses the effects of home-based nursing on morbidity in people infected with HIV/AIDS.Entities:
Keywords: Adherence to antiretroviral drugs; HIV/AIDS; Home-based care; Nurse-led care; Psychosocial support
Mesh:
Year: 2018 PMID: 29587719 PMCID: PMC5870334 DOI: 10.1186/s12913-018-3002-4
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Fig. 1Home-based care as a management strategy for people with HIV
MEDLINE search strategy
| Search | Most recent queries |
|---|---|
| #1 | Search HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tw] OR hiv-1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw] OR hiv infect*[tw] OR human immunodeficiency virus[tw] OR human immunedeficiency virus[tw] OR human 19rospe-deficiency virus[tw] OR human immune-deficiency virus[tw] OR ((human 19rospe*) AND (deficiency virus[tw])) OR acquired immunodeficiency syndrome[tw] OR acquired immunedeficiency syndrome[tw] OR acquired 19rospe-deficiency syndrome[tw] OR acquired immune-deficiency syndrome[tw] OR ((acquired 19rospe*) AND (deficiency syndrome[tw])) OR “Sexually Transmitted Diseases, Viral”[MeSH:NoExp] |
| #2 | Search randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random allocation [mh] OR double-blind method [mh] OR single-blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR (“clinical trial” [tw]) OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR (placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp] OR comparative study [mh] OR evaluation studies [mh] OR follow-up studies [mh] OR prospective studies [mh] OR control* [tw] OR 19rospective* [tw] OR volunteer* [tw]) NOT (animals [mh] NOT human [mh]) |
| #3 | Search Home-based care or homebased care or home based care |
| #4 | Search Home care or homecare or home-care |
| #5 | Search Home |
| #6 | Search #3 OR #4 OR #5 |
| #7 | Search #1 AND #2 AND #6 |
Fig. 2Flow diagram of study selection
Table of excluded studies
| Reason for exclusion | Number of studies [references] |
|---|---|
| Not all participants are HIV positive | 3 studies [ |
| Intervention studied was not home-based care | 5 studies [ |
| Intervention was not provided by qualified nurses | 15 studies [ |
| Comparison of two models of home-based care | 2 studies [ |
| Study investigating home-based voluntary HIV counselling and testing | 12 studies [ |
| Not a randomised controlled trial | 12 studies [ |
| Trial terminated for non-compliance with human subject regulations | 1 study [ |
Description of included studies
| Category | Type of intervention and comparison | Study ID | Participants | Follow-up duration | Study location | Outcomes |
|---|---|---|---|---|---|---|
| Adherence support | Home-based nursing vs. standard care | Berrien 2004 [ | HIV-positive children. | 12 months. | Connecticut, USA. | Adherence; Viral load; CD4 count. |
| Wang 2010 [ | HIV-positive adults; active or previous heroin addicts; on ART at least 1 month prior to starting study. | 10 months. | Hunan, China. | Adherence. | ||
| Williams 2006 [ | HIV-positive adults on ART. | 15 months. | Connecticut, USA. | Adherence; Viral load; CD4 count. | ||
| Williams 2014 [ | HIV-positive adults; on ART; self-reported < 90% adherence to pre-ART medications or to ART; willing to receive home visits. | 12 months. | Hunan, China. | Adherence; Viral load; CD4 count. | ||
| Improved psycho-social wellbeing | Home based nursing vs. standard care | Blank 2014 [ | HIV-positive adults; understand spoken English; had a diagnosed serious mental illness; able to provide informed consent. | 24 months. | Philadelphia, USA. | Health related quality of life; Viral load; CD4 count. |
| Hanrahan 2011 [ | HIV-positive adults; lived within the city limits of Philadelphia; had a diagnosed serious mental illness (SMI). | 12 months. | Philadelphia, USA. | Psychiatric symptoms; Health related quality of life | ||
| Miles 2003 [ | African American women with HIV who were primary caregivers for at least one child under the age of 9 years. | 6 months. | USA. | Emotional distress (depression, stigma, worry); Health related quality of life | ||
| Wang 2010 [ | HIV-positive adults; active or previous heroin addicts; on ART at least 1 month prior to starting study. | 10 months. | Hunan, China. | Quality of life, Depression | ||
| Williams 2014 [ | HIV-positive adults; on ART; self-reported < 90% adherence to pre-ART medications or to ART; willing to receive home visits. | 12 months. | Hunan, China. | Depressive symptoms; social support; HIV stigma scale. |
Risk of bias of included studies
| Bias | Berrien 2004 [ | Blank 2014 [ | Hanrahan 2011 [ | Miles 2003 [ | Wang 2010 [ | Williams 2006 [ | Wiliams 2014 [ |
|---|---|---|---|---|---|---|---|
| Random sequence generation | Small table of random digits. | Randomised on a 1:1 basis but method unclear. | Computer-generated algorithm | Table of random numbers. | Not reported. | Stratified randomisation, with block size of 10. | Stratified randomisation, with block size of 10. |
| Allocation concealment | Randomisation list held by clinical coordinator of HIV program, kept in a locked file. | Not reported. | Person allocating different from the one assessing the inclusion. | Not reported. | Not reported. | Not reported. | Not reported. |
| Incomplete outcome data | Lost to follow-up: 5% intervention; 11% control. | Lost to follow up not reported. | Lost to follow-up: 10% intervention; 5% control. | Lost to follow-up at 6 months: 51% intervention; 58% control. | Lost to follow-up: 14% intervention; 17% control. | Lost to follow-up at 12 months: 28% intervention; 25% control. | Lost to follow-up at 12 months: 5% intervention; 22% control. |
| Selective reporting | All outcomes reported. | All outcomes reported. | All outcomes reported. | All outcomes reported. | All outcomes reported. | All outcomes reported. | Incomplete reporting of social support and stigma. |
| Blinding of participants and personnel | None. | Participants not blinded. | None. | None. | Not reported. | All personnel were blinded except the home visit team. Participants not blinded. | None. |
| Blinding of outcome assessment | None. | Research staff blinded. Participants disclosed information, unmasking experimental status. | Data collectors blinded. | Data collectors blinded. | Not reported. | All personnel including interviewers were blinded except the home visit team. | Not reported. |
Summary of results
| Outcomes | Summary | |
|---|---|---|
| Adherence support | Adherence | -Self-reported adherence improved with intervention [ |
| Viral load | No significant change [ | |
| CD4 count | No significant change [ | |
| Improved psycho-social wellbeing | Health-related quality of life | -SF-12 mental health subscale improved with intervention but not the SF-12 physical health subscale [ |
| Psychiatric symptoms | No significant difference between groups in reduction in psychiatric symptoms (Colorado Symptom Index (CSI) score) [ | |
| Emotional distress (depression, stigma, worry) | -Reduced symptoms of depression (PHQ-9 score) with intervention [ |
Summary of systematic reviews on community-based care for HIV
| Review | Date of search, number of included studies | Participants | Intervention | Comparison | Outcomes | Summary of key findings |
|---|---|---|---|---|---|---|
| Decroo 2013 [ | Feb 2013. | PLWHA | -Home-based ART delivery by CHWs. | Facility based ART | -Attrition on ART. | -Increase adherence and accessibility to AR. |
| Kredo 2013 [ | March 2013. | HIV-infected patients at point of initiating treatment and patients already on treatment requiring maintenance and follow-up. | Any form of decentralised care delivery model for initiation or continuation of treatment, or both. | Care delivered at centralised site (usually a hospital or health facility) | -Attrition (composite of loss to follow up or death). | -Lower attrition in partial decentralisation models (ART started in hospital and continued at health centre). |
| Mwai 2013 [ | December 2012. | PLWH | CHWs in HIV | Facility based HIV care | Patient related: | CHWs perform a variety of roles in HIV including counselling, testing, home-based care, education, adherence support, livelihood support, screening, referral and surveillance activities, retention in care. |
| Nachega 2016 [ | January 2016. | HIV-infected individuals initiated on ART. | Community-based ART delivery. | Health-care facility (e.g. hospital or clinic) | -Proportion of PLWHA with optimal ART adherence levels (> 80%). | -No significant difference in optimal ART adherence, virological suppression, all-cause mortality and loss to follow-up between 2 groups when analysis was restricted to RCTs. |
| Rachlis 2013 [ | December 2011, updated February 2012. | Urban /rural populations including PLWHA, their family members, orphans, vulnerable children. | Community-based care (CBC) programmes | -Region | 9 key categories useful for describing and organising CBC HIV/AIDS programs in resource limited settings. Suggest can be used to inform potential logic models to enhance overall program performance and to develop evidence based tools for sustainable HIV/AIDS service delivery. | |
| Wouters 2012 [ | December 2011. | PLWHA | 9 types community support providers: | Health facility based care | ART programme outcomes: | Community support can positively impact ART programme delivery and outcomes in resource-limited settings. |